NFKB1 and metabolic syndrome: In the present study, we investigated the expression of NF-κB, a transcription factor mediating the inflammatory response, Nrf2 as a critical regulator of defense against oxidative stress, HO-1, an endothelial protector and antioxidant, and the relationship between them and plasma MDA and ADMA in people with MetS.